The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1079
ISSUE1079
May 29, 2000
Meloxicam (Mobic) for Osteoarthritis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Meloxicam (Mobic) for Osteoarthritis
May 29, 2000 (Issue: 1079)
Meloxicam, a nonsteroidal anti-inflammatory drug (NSAID) with some cyclooxygenase-2 (COX-2) selectivity in vitro, has been approved by the FDA for treatment of osteoarthritis.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.